---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-25-081880"
form_type: "8-K"
ticker: "RCEL"
cik: "0001762303"
company_name: "AVITA Medical, Inc."
filed_at: "2025-06-05T23:59:59+00:00"
generated_at: "2026-05-19T22:22:34.595934+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# AVITA Medical shareholders approve amended incentive plan, increase share reserve by 2.5M

## Summary
- Amended 2020 Omnibus Incentive Plan approved, increasing share reserve by 2.5M to 6.75M shares.
- All seven director nominees elected; for-votes ranged from 8.6M to 10.0M across candidates.
- Ratified Grant Thornton as independent auditor for FY2025 with 13.4M votes for.
- Approved grants to each of six non-executive directors: 10,022 RSUs and 4,295 options each.
- Approved grant of options to acquire 520,000 shares to CEO James Corbett.

## SEC filing metadata
- accession: 0000950170-25-081880
- form_type: 8-K
- ticker: RCEL
- cik: 0001762303
- company_name: AVITA Medical, Inc.
- filed_at: 2025-06-05T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/0000950170-25-081880-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1762303/000095017025081880/rcel-20250604.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-25-081880
- JSON: https://secwatch.observer/filing/0000950170-25-081880.json
- Plain text: https://secwatch.observer/filing/0000950170-25-081880.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.